TrialThe Journal of international medical research2020

Ranibizumab plus fufang xueshuantong capsule versus ranibizumab alone for exudative age-related macular degeneration.

Hai-Tao Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.